Sellas Life Sciences Group, Inc. · NASDAQ:SLS
Anson Funds Management LP's stake in Sellas Life Sciences Group, Inc. fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Anson Funds Management LP's stake in Sellas Life Sciences Group, Inc. fell to 4.90%, 5,225,948 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 5,225,948
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Anson Funds Management LP | 4.90% | 5,225,948 |
| Anson Management GP LLC | 4.90% | 5,225,948 |
| Tony Moore | 4.90% | 5,225,948 |
| Anson Advisors Inc. | 4.90% | 5,225,948 |
| Amin Nathoo | 4.90% | 5,225,948 |
| Moez Kassam | 4.90% | 5,225,948 |
Source
Related
- Sellas Life Sciences Group, Inc.
- Anson Funds Management LP
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026
- Schedule 13G · Anson Funds Management LP · Nov 14, 2025
- Schedule 13G · Anson Funds Management LP · May 15, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026